研報掘金丨國聯民生證券:長城汽車新能源和出海保持高增速,維持“買入”評級
國聯民生證券研報指出,長城汽車(601633.SH)3月實現汽車銷量9.8萬輛,同比-2.3%,環比+25.8%;1-3月累計汽車銷量25.7萬輛,同比-6.7%。3月公司2025款哈弗H5/二代梟龍MAX/2025款坦克300上市,其中二代梟龍MAX 預售72小時大訂訂單突破10636 輛,隨着公司多款新車陸續上市以及以舊換新政策效果逐步體現,看好公司後續銷量表現。公司持續推進品牌向上,新能源和出海保持高增速,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.